Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | KCNA5 | P22460 | 5/20 | 0.48 |
| ▸ | SCN5A | Q14524 | 5/20 | 0.48 |
| ▸ | KCND2 | Q9NZV8 | 5/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13326288 | 1.00 | SLC6A4 (0.48) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL18596764 | 0.83 | SLC6A4 (0.51) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL3338757 | 0.79 | CHRM5 (0.48) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL16706902 | 0.78 | SLC6A4 (0.57) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL28914412 | 0.77 | CPB1 (0.58) | EPHX1CPB1ALDH1A1TSHR | |
| SCHEMBL19630135 | 0.77 | CPB1 (0.58) | EPHX1CPB1ALDH1A1TSHR | |
| SCHEMBL28914414 | 0.77 | CPB1 (0.58) | EPHX1CPB1ALDH1A1TSHR | |
| SCHEMBL20749075 | 0.77 | CPB1 (0.58) | EPHX1CPB1ALDH1A1TSHR | |
| SCHEMBL2632423 | 0.76 | SLC6A4 (0.52) | SLC6A4KCNA5SCN5AKCND2KCNH2 | |
| SCHEMBL13326777 | 0.76 | SLC6A4 (0.58) | SLC6A4KCNA5SCN5AKCND2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069404-A1 | DEUTERIUM-ENRICHED VERNAKALANT | PROTIA, LLC (US) | 2009-03-12 | — | — | US | disclosed |
| US-20090069404-A1 | DEUTERIUM-ENRICHED VERNAKALANT | PROTIA, LLC (US) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069404-A1 | DEUTERIUM-ENRICHED VERNAKALANT | VRK1, VRK2, VDR | SLC6A4 594/4885KCNA5 1420/4885SCN5A 1397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.